Patents by Inventor Werner Stüber

Werner Stüber has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 7201260
    Abstract: A subassembly for the amplitude-dependent absorption of shock, especially in a dashpot for a motor vehicle with a piston and an oscillating piston rod. The piston (3) is accommodated in a housing (2), partitioning the housing into two compartments (4 & 5), and travels up and down inside the housing, radially aligned and axially subject to motion-limiting tension, on the end of the piston rod (1). The object is a simple and reliable subassembly that takes up little additional space. The piston is accordingly axially tensioned between two springs (17 & 18).
    Type: Grant
    Filed: May 26, 2004
    Date of Patent: April 10, 2007
    Assignee: ThyssenKrupp Bilstein GmbH
    Inventors: Manfred Diederich, Jan Kirch, Werner Stüber
  • Patent number: 6932968
    Abstract: Erythropoietin (EPO) peptides and the use thereof for preparing epitope-specific anti-EPO antibodies are described. Also described are corresponding anti-EPO antibodies which take the form of polyclonal antibodies (antisera) or of monoclonal antibodies. These antibodies are suitable for purifying EPO, EPO derivatives or EPO peptides. The epitope-specific anti-EPO antibodies according to the invention can also be used for the detection of EPO and, in particular, for the epitope-specific detection of EPO. Additionally described are anti-idiotype antibodies which imitate a receptor region of EPO. Finally, pharmaceuticals which contain the EPO peptides, anti-EPO antibodies or anti-idiotype antibodies, and diagnostic aids for the detection of EPO or of anti-EPO antibodies, are described.
    Type: Grant
    Filed: July 21, 1997
    Date of Patent: August 23, 2005
    Assignee: Dade Behring Marburg GmbH
    Inventors: Mathias Fibi, Werner Stüber
  • Patent number: 6566085
    Abstract: The invention relates to synthetic peptides which have amino acid sequences which correspond, in whole or in part, to the amino acid sequence of prothrombin and are antigenic, to the use thereof for the immunization of an animal and for the purification of specific antibodies, to antibodies against these peptides, and to the use of the antibodies for the determination of the fragments F2/F1+2.
    Type: Grant
    Filed: November 20, 1991
    Date of Patent: May 20, 2003
    Assignee: Dade Behring Marburg GmbH
    Inventors: Hermann Pelzer, Werner Stüber
  • Patent number: 6538113
    Abstract: The invention relates to synthetic peptides which have amino acid sequences which correspond, in whole or in part, to the amino acid sequence of prothrombin and are antigenic, to the use thereof for the immunization of an animal and for the purification of specific antibodies, to antibodies against these peptides, and to the use of the antibodies for the determination of the fragments F2/F1+2. The antibodies hitherto used for the determination of the content of the fragments F2/F1+2 have been induced by immunization with natural, highly purified prothrombin fragments F2/F1+2. The isolation of these prothrombin fragments is elaborate and costly, and the antibodies generated therewith show cross-reactions with intact prothrombin. Used for the immunization according to the invention are synthetic peptides which have amino acid sequences which correspond, in whole or in part, to the amino acid sequence of prothrombin and are antigenic.
    Type: Grant
    Filed: June 7, 1995
    Date of Patent: March 25, 2003
    Assignee: Dade Behring Marburg GmbH
    Inventors: Hermann Pelzer, Werner Stüber
  • Patent number: 6441141
    Abstract: The present invention is directed to the generation of antibodies which preferentially bind to fibrinogen fragments E1, E2 and E3, but exhibit little or no cross-reactivity against fibrin monomer and fibrinogen. Thus, the invention provides synthetic peptides containing defined amino acid sequences corresponding to the carboxy terminal regions of the E fragments which arise as a result of plasmin cleavage of fibrin and fibrinogen. The synthetic peptides may be synthesized chemically, or through genetic manipulations, and may contain additional amino acid sequences which are not contiguous with the defined E fragment sequences.
    Type: Grant
    Filed: September 29, 1999
    Date of Patent: August 27, 2002
    Assignee: Dade Behring Marburg GmbH
    Inventors: Michael Kraus, Werner Stüber